Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism IP6K1 inhibitors(inositol hexakisphosphate kinase 1 inhibitors), IP6K2 inhibitors(inositol hexakisphosphate kinase 2 inhibitors), IP6K3 inhibitors(inositol hexakisphosphate kinase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperphosphatemia | Phase 1 | Japan | 14 Mar 2017 | |
Ovarian clear cell carcinoma | Preclinical | Japan | 14 Sep 2024 |